Brookfield to acquire a $4.8B stake in Oaktree Capital Management

By Nikita Chaurasia  Date: 2019-03-15

Brookfield to acquire a $4.8B stake in Oaktree Capital Management
  • With the acquisition, Brookfield aims to compete with industry giants such as the Blackstone Group.
     
  • The deal makes Oaktree the second American alternative-asset manager to carry out such a transaction in recent years.

Brookfield Asset Management Inc., (Brookfield), a Canadian alternative-asset management firm, has reportedly announced the $4.8 billion majority stake acquisition of California-based asset management firm, Oaktree Capital Management (Oaktree).

Reports cite, the deal makes Oaktree the second American alternative-asset manager to carry out such a transaction in recent years. With the acquisition, Brookfield aims to compete with industry giants such as the Blackstone Group.

According to a report by Bloomberg, under the terms of the agreement, Brookfield would be acquiring a 62% majority stake in Oaktree Capital in a cash & stock deal. The two firms would together have over $475 billion worth of combined assets under their management and a fee-related annual revenue of $2.5 billion.

The Chief Executive Officer of Brookfield Asset Management, Bruce Flatt stated that the deal enables the company to significantly broaden its product portfolio to include one of the world’s finest credit platforms, which boasts of a value-propelled contrarian investment style that is consistent with the company’s.

For the record, leading industry player Blackstone boasted of $472 billion worth of assets under its management by the end of 2018. This valuation does not account for the debt, if the debt is counted, assets under Blackstone’s management would be around $650 billion.

As part of the acquisition deal, Oaktree shareholders would be able to exchange their respective shares for either 1.0770 Brookfield Class A shares or for a cash payment of $49 per share. The proposed offer is approximately 12.4% premium of Oaktree Class A shares, as per the latest closing price.

According to reports, the amount to be paid for the Oaktree majority stake would be made 50% in cash and 50% stock.

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

France might ban short domestic flights to reduce its carbon footprint

France might ban short domestic flights to reduce its carbon footprint

By Nikita Chaurasia

French lawmakers recently came to a unanimous decision to ban domestic flights for distances that can be covered by train in over two-and-a-half- hours. The country aims to impose these restrictions in an effort to reduce carbon emissions, even as th...

Kavak secures USD 485 million in funding, eyes Latin America expansion

Kavak secures USD 485 million in funding, eyes Latin America expansion

By Nikita Chaurasia

Kavak, a Mexico-based used-car platform, has reportedly reached a valuation of USD 4 billion after securing USD 485 million during a new funding round. This makes it the fastest-growing as well as the most valued company in Latin America. The latest...

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

By Nikita Chaurasia

Indian pharmaceutical company Zydus Cadila is reportedly seeking approval from DCGI (Drug Controller General of India) for its PegIFN (Pegylated Interferon Alpha-2b), a hepatitis C drug, to treat COVID-19 patients, after its third phase of clinical t...

LinkedIn confirms launch of a social audio platform to rival Clubhouse

LinkedIn confirms launch of a social audio platform to rival Clubhouse

By Nikita Chaurasia

LinkedIn, the popular employment-oriented online service, has confirmed that it is testing a social audio experience in its app which could offer users with better connectivity in their networks. Although several social media giants such as Twitter ...

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

By Nikita Chaurasia

Pfizer Inc., an American multinational pharmaceutical corporation, has recently announced to have started the early phase trials for its oral antiviral drug for Coronavirus. The company revealed that first phase trials of the experimental drug, PF-07...